FDA 483 - Bajaj Nutraceuticals - November 29, 2024

Bajaj Nutraceuticals in Bhagwanpur, India, was inspected by the FDA, resulting in a Form 483. The inspection identified a significant deficiency concerning the firm's quality control unit. Specifically, the firm failed to establish written procedures for the comprehensive review of test data and instrument logbooks.